Genetic diversity of G9P[8] rotavirus strains circulating in Italy in 2007 and 2010 as determined by whole genome sequencing

Infection, Genetics and Evolution

Volumn 16, Issue , 2013, Pages 426-432

  Ianiro, G ^a   Heylen, E ^b   Delogu, R ^a   Zeller, M ^b   Matthijnssens, J ^b   Ruggeri, F M ^a   Van Ranst, M ^b   Fiore, L ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Full genome sequencing; G9P 8 ; Italy; Rotavirus; VP4; VP7

Indexed keywords

NONSTRUCTURAL PROTEIN 2; PROTEIN VP4; PROTEIN VP7; PROTEIN VP8; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACUTE DIARRHEA; ARTICLE; CONTROLLED STUDY; GENE; GENE SEQUENCE; GENETIC VARIABILITY; ITALY; MOLECULAR PHYLOGENY; NONHUMAN; NSP2 GENE; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; SEQUENCE ANALYSIS; VIRUS STRAIN; VP4 GENE; VP7 GENE; WHOLE GENOME SEQUENCING;

ANTIGENS, VIRAL; CAPSID PROTEINS; DIARRHEA; GENETIC VARIATION; GENOME, VIRAL; GENOTYPE; HUMANS; ITALY; PHYLOGENY; RNA, VIRAL; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEQUENCE ANALYSIS, RNA;

ROTAVIRUS;

EID: 84876435029     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.03.031     Document Type: Article

References (56)

1. Aoki S.T., Settembre E.C., Trask S.D., Greenberg H.B., Harrison S.C., Dormitzer P.R. Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab. Science 2009, 324:1444-1447.
2. Aoki S.T., Trask S.D., Coulson B.S., Greenberg H.B., Dormitzer P.R., Harrison S.C. Cross-linking of rotavirus outer capsid protein VP7 by antibodies or disulfides inhibits viral entry. Journal of Virology 2011, 85:10509-10517.
3. Banyai K., Laszlo B., Duque J., Steele A.D., Nelson E.A., Gentsch J.R., Parashar U.D. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine 2012, 30(Suppl. 1):A122-A130.
4. Beards G.M., Pilfold J.N., Thouless M.E., Flewett T.H. Rotavirus serotypes by serum neutralisation. Journal of Medical Virology 1980, 5:231-237.
5. Coulson B.S. Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies. Journal of Clinical Microbiology 1993, 31:1-8.
6. Donato C.M., Cannan D., Bogdanovic-Sakran N., Snelling T.L., Kirkwood C.D. Characterisation of a G9P[8] rotavirus strain identified during a gastroenteritis outbreak in alice springs Australia post rotarix vaccine introduction. Vaccine 2012, 30(Suppl. 1):A152-A158.
7. Dormitzer P.R., Sun Z.Y., Wagner G., Harrison S.C. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. The EMBO Journal 2002, 21:885-897.
8. * from rhesus rotavirus. Archives of Virology 1995, 140:1969-1978.
9. Estes M.K., Kapikian A.Z. Rotaviruses. Fields Virology 2007, 1918-1974. Lippincott, Williams & Wilkins, Philadelphia, PA. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
10. Gentsch J.R., Glass R.I., Woods P., Gouvea V., Gorziglia M., Flores J., Das B.K., Bhan M.K. Identification of group A rotavirus gene 4 types by polymerase chain reaction. Journal of Clinical Microbiology 1992, 30:1365-1373.
11. Gentsch J.R., Hull J.J., Teel E.N., Kerin T.K., Freeman M.M., Esona M.D., Griffin D.D., Bielfelt-Krall B.P., Banyai K., Jiang B., Cortese M.M., Glass R.I., Parashar U.D. G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data. The Journal of Infectious Diseases 2009, 200(Suppl. 1):S99-S105.
12. Ghosh S., Paul S.K., Yamamoto D., Nagashima S., Kobayashi N. Full genomic analyses of human rotavirus strains possessing the rare P[8]b VP4 subtype. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2011, 11:1481-1486.
13. Giammarioli A.M., Mackow E.R., Fiore L., Greenberg H.B., Ruggeri F.M. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus. Virology 1996, 225:97-110.
14. Gouvea V., Glass R.I., Woods P., Taniguchi K., Clark H.F., Forrester B., Fang Z.Y. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. Journal of Clinical Microbiology 1990, 28:276-282.
15. Greenberg H.B., Flores J., Kalica A.R., Wyatt R.G., Jones R. Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. The Journal of General Virology 1983, 64(Pt 2):313-320.
16. Hagbom M., Istrate C., Engblom D., Karlsson T., Rodriguez-Diaz J., Buesa J., Taylor J.A., Loitto V.M., Magnusson K.E., Ahlman H., Lundgren O., Svensson L. Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomiting. PLoS Pathogens 2011, 7:e1002115.
17. Hoshino Y., Sereno M.M., Midthun K., Flores J., Kapikian A.Z., Chanock R.M. Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:8701-8704.
18. Ijaz M.K., Attah-Poku S.K., Redmond M.J., Parker M.D., Sabara M.I., Frenchick P., Babiuk L.A. Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus. Journal of Virology 1991, 65:3106-3113.
19. Iturriza-Gomara M., Dallman T., Banyai K., Bottiger B., Buesa J., Diedrich S., Fiore L., Johansen K., Koopmans M., Korsun N., Koukou D., Kroneman A., Laszlo B., Lappalainen M., Maunula L., Marques A.M., Matthijnssens J., Midgley S., Mladenova Z., Nawaz S., Poljsak-Prijatelj M., Pothier P., Ruggeri F.M., Sanchez-Fauquier A., Steyer A., Sidaraviciute-Ivaskeviciene I., Syriopoulou V., Tran A.N., Usonis V., Van Ranst M., De Rougemont A., Gray J. Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiology and Infection 2011, 139:895-909.
20. Iturriza-Gomara M., Kang G., Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2004, 31:259-265.
21. Kobayashi N., Taniguchi K., Urasawa T., Urasawa S. Analysis of the neutralization epitopes on human rotavirus VP7 recognized by monotype-specific monoclonal antibodies. The Journal of General Virology 1991, 72(Pt 8):1855-1861.
22. Linhares A.C., Velazquez F.R., Perez-Schael I., Saez-Llorens X., Abate H., Espinoza F., Lopez P., Macias-Parra M., Ortega-Barria E., Rivera-Medina D.M., Rivera L., Pavia-Ruz N., Nunez E., Damaso S., Ruiz-Palacios G.M., De Vos B., O'Ryan M., Gillard P., Bouckenooghe A. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008, 371:1181-1189.
23. Maes P., Matthijnssens J., Rahman M., Van Ranst M. RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiology 2009, 9:238.
24. Matsui S.M., Mackow E.R., Greenberg H.B. Molecular determinant of rotavirus neutralization and protection. Advances in Virus Research 1989, 36:181-214.
25. Matsui S.M., Offit P.A., Vo P.T., Mackow E.R., Benfield D.A., Shaw R.D., Padilla-Noriega L., Greenberg H.B. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. Journal of Clinical Microbiology 1989, 27:780-782.
26. Matthijnssens J., Ciarlet M., Heiman E., Arijs I., Delbeke T., McDonald S.M., Palombo E.A., Iturriza-Gomara M., Maes P., Patton J.T., Rahman M., Van Ranst M. Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. Journal of Virology 2008, 82:3204-3219.
27. Matthijnssens J., Ciarlet M., McDonald S.M., Attoui H., Banyai K., Brister J.R., Buesa J., Esona M.D., Estes M.K., Gentsch J.R., Iturriza-Gomara M., Johne R., Kirkwood C.D., Martella V., Mertens P.P., Nakagomi O., Parreno V., Rahman M., Ruggeri F.M., Saif L.J., Santos N., Steyer A., Taniguchi K., Patton J.T., Desselberger U., Van Ranst M. Uniformity of rotavirus strain nomenclature proposed by the rotavirus classification working group (RCWG). Archives of Virology 2011, 156:1397-1413.
28. Matthijnssens J., Ciarlet M., Rahman M., Attoui H., Banyai K., Estes M.K., Gentsch J.R., Iturriza-Gomara M., Kirkwood C.D., Martella V., Mertens P.P., Nakagomi O., Patton J.T., Ruggeri F.M., Saif L.J., Santos N., Steyer A., Taniguchi K., Desselberger U., Van Ranst M. Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Archives of Virology 2008, 153:1621-1629.
29. Matthijnssens J., Heylen E., Zeller M., Rahman M., Lemey P., Van Ranst M. Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Molecular Biology and Evolution 2010, 27:2431-2436.
30. Matthijnssens J., Rahman M., Martella V., Xuelei Y., De Vos S., De Leener K., Ciarlet M., Buonavoglia C., Van Ranst M. Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmission. Journal of Virology 2006, 80:3801-3810.
31. Matthijnssens J., Van Ranst M. Genotype constellation and evolution of group A rotaviruses infecting humans. Current Opinion in Virology 2012, 2:1-8.
32. McDonald S.M., Davis K., McAllen J.K., Spiro D.J., Patton J.T. Intra-genotypic diversity of archival G4P[8] human rotaviruses from Washington, DC. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2011, 11:1586-1594.
33. McDonald S.M., Matthijnssens J., McAllen J.K., Hine E., Overton L., Wang S., Lemey P., Zeller M., Van Ranst M., Spiro D.J., Patton J.T. Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellations. PLoS Pathogens 2009, 5:e1000634.
34. Mijatovic-Rustempasic S., Banyai K., Esona M.D., Foytich K., Bowen M.D., Gentsch J.R. Genome sequence based molecular epidemiology of unusual US rotavirus A G9 strains isolated from Omaha, USA between 1997 and 2000. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2011, 11:522-527.
35. Offit P.A., Blavat G. Identification of the two rotavirus genes determining neutralization specificities. Journal of Virology 1986, 57:376-378.
36. Offit P.A., Dudzik K.I. Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes. Journal of Virology 1988, 62:127-131.
37. Ogilvie I., Khoury H., Goetghebeur M.M., El Khoury A.C., Giaquinto C. Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review. BMC Infectious Diseases 2012, 12:62.
38. Otto P., Schulze P., Herbst W. Demonstration of group C rotaviruses in fecal samples of diarrheic dogs in Germany. Archives of Virology 1999, 144:2467-2473.
39. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerging Infectious Diseases 2003, 9:565-572.
40. Phan T.G., Okitsu S., Maneekarn N., Ushijima H. Genetic heterogeneity, evolution and recombination in emerging G9 rotaviruses. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2007, 7:656-663.
41. Pietsch C., Liebert U.G. Human infection with G12 rotaviruses, Germany. Emerging Infectious Diseases 2009, 15:1512-1515.
42. Rahman M., Matthijnssens J., Yang X., Delbeke T., Arijs I., Taniguchi K., Iturriza-Gomara M., Iftekharuddin N., Azim T., Van Ranst M. Evolutionary history and global spread of the emerging g12 human rotaviruses. Journal of Virology 2007, 81:2382-2390.
43. Ramig R.F. Genetics of the rotaviruses. Annual Review of Microbiology 1997, 51:225-255.
44. Ruggeri F.M., Delogu R., Petouchoff T., Tcheremenskaia O., De Petris S., Fiore L. Molecular characterization of rotavirus strains from children with diarrhea in Italy, 2007-2009. Journal of Medical Virology 2011, 83:1657-1668.
45. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., Cheuvart B., Espinoza F., Gillard P., Innis B.L., Cervantes Y., Linhares A.C., Lopez P., Macias-Parra M., Ortega-Barria E., Richardson V., Rivera-Medina D.M., Rivera L., Salinas B., Pavia-Ruz N., Salmeron J., Ruttimann R., Tinoco J.C., Rubio P., Nunez E., Guerrero M.L., Yarzabal J.P., Damaso S., Tornieporth N., Saez-Llorens X., Vergara R.F., Vesikari T., Bouckenooghe A., Clemens R., De Vos B., O'Ryan M. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. The New England Journal of Medicine 2006, 354:11-22.
46. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Reviews in Medical Virology 2005, 15:29-56.
47. Shaw R.D., Mackow E.R., Dyall-Smith M.L., Lazdins I., Holmes I.H., Greenberg H.B. Serotypic analysis of VP3 and VP7 neutralization escape mutants of rhesus rotavirus. Journal of Virology 1988, 62:3509-3512.
48. Shin J.W., Le V.P., Than V.T., Lim I., Yoon Y., Kim K., Chung S.I., Myung S.C., Kim W. Genomic characterization of a cell-culture-adapted Korean human G9P[8] rotavirus, CAU05-202. Archives of Virology 2012, 157:753-759.
49. Siqueira A.A., Santelli A.C., Alencar L.R., Dantas M.P., Dimech C.P., Carmo G.M., Santos D.A., Alves R.M., Lucena M.B., Morais M., Assis R.M., Fialho A., Mascarenhas J.D., Costa M., Linhares A.C., Leite J.P., Araujo W.N., Hatch D.L. Outbreak of acute gastroenteritis in young children with death due to rotavirus genotype G9 in Rio Branco, Brazilian Amazon region, 2005. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases 2010, 14:e898-e903.
50. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Molecular Biology and Evolution 2011, 28:2731-2739.
51. Tate J.E., Burton A.H., Boschi-Pinto C., Steele A.D., Duque J., Parashar U.D. 2008 Estimate of worldwide rotavirus-associated mortality in children younger than 5years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. The Lancet Infectious Diseases 2012, 12:136-141.
52. Trojnar E., Sachsenroder J., Twardziok S., Reetz J., Otto P.H., Johne R. Identification of an avian group A rotavirus containing a novel VP4 gene with a close relationship to those of mammalian rotaviruses. The Journal of General Virology 2013, 94:136-142.
53. Vesikari T., Clark H.F., Offit P.A., Dallas M.J., DiStefano D.J., Goveia M.G., Ward R.L., Schodel F., Karvonen A., Drummond J.E., DiNubile M.J., Heaton P.M. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. Vaccine 2006, 24:4821-4829.
54. Ward R.L., Kirkwood C.D., Sander D.S., Smith V.E., Shao M., Bean J.A., Sack D.A., Bernstein D.I. Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12. The Journal of Infectious Diseases 2006, 194:1729-1736.
55. Wolf M., Vo P.T., Greenberg H.B. Rhesus rotavirus entry into a polarized epithelium is endocytosis dependent and involves sequential VP4 conformational changes. Journal of Virology 2011, 85:2492-2503.
56. Zhou Y.J., Burns J.W., Morita Y., Tanaka T., Estes M.K. Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure. Journal of Virology 1994, 68:3955-3964.